Loading...
OTC Markets
Totals
Securities
12,255
Dollar Vol
$2.6B
Share Vol
3.2B
Trades
383,044

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

XBIO
Xenetic Biosciences, Inc.

Common Stock

2.77

-0.20

-6.73%

Delayed (15 Min) Trade Data: 12:00am 08/08/2025
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All
Publish Date
Publish Date
Title
Title
Period End Date
Period End Date
Status
Status
06/30/2016OTCQB Certification12/31/2015A
05/02/2016OTCQB Certification12/31/2015A
04/29/2015OTCQB Certification12/31/2014A
04/27/2015OTCQB Certification12/31/2014A
03/13/2015OTCQB Certification03/13/2015A
More
Displaying 5 of 5 Disclosure & News
SEC Filings
Form Type
Form Type
Received
Received
Period End Date
Period End Date
Report
Report
8-K05/14/202505/14/2025PDFRTFHTMLXLS
10-Q05/13/202503/31/2025PDFRTFHTMLXLS
10-K/A05/13/202512/31/2024PDFRTFHTMLXLS
10-K/A04/29/202512/31/2024PDFRTFHTMLXLS
8-K04/10/202504/08/2025PDFRTFHTMLXLS
8-K/A03/19/202503/19/2025PDFRTFHTMLXLS
8-K03/19/202503/19/2025PDFRTFHTMLXLS
10-K03/18/202512/31/2024PDFRTFHTMLXLS
412/13/202412/11/2024PDFRTFHTMLXLS
412/13/202412/11/2024PDFRTFHTMLXLS
More
Displaying 10 of 409 Filings
Insider Disclosure
OTC Disclosure & News

No insider disclosure available for XBIO.

SEC Transactions Last 6 Months
Buy / Sell
Buys
0
Sells
0
Total
0
Shares
Bought
0
Sold
0
Gross
0
Net
0
SEC Transactions Last 2 Years
Trans Date
Trans Date
Filer
Filer
Ownership
Ownership
Type
Type
Price
Price
Shares Traded
Shares Traded
Shares Held
Shares Held
12/06/2023MIZRAHY MOSHE
Director
Direct0
More
Nasdaq
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.